Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Matthew Appenzeller (NPI 1235340522)

Field	Value
Entity Type	Individual
Organization	Matthew Appenzeller
Address	4353 Dodge St
City	Omaha
State	NE
ZIP	68131
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 25, 2007

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

MATTHEW APPENZELLER is an Ophthalmology Physician in OMAHA, NE with an NPI enumerated on 2007-05-25 (~19 years ago), indicating long tenure in Medicare billing and likely an established referral base and practice operations. The provider’s lifetime Medicare revenue is $2.5M and there is no Medicaid billing on file, so Medicare is effectively the sole public-payer exposure reported.

Revenue is highly concentrated in intravitreal treatment and related retinal services: the precomputed top 3 Medicare codes (J0178, J2777, 67028) account for 75.9% of the provider’s total Medicare revenue, with J0178 ($891K, 35.8%) and J2777 ($852.6K, 34.2%) together making up the single largest share of billing. This concentration signals dependence on anti-VEGF/ocular biologic administration as the primary revenue driver.

The code mix and descriptions point to a retina-focused procedural practice model: heavy billing for injection drugs (J0178, J2777, J0179, J2778) and a high volume of posterior-segment imaging (92134) suggest routine intravitreal injection clinics supported by frequent retinal imaging and follow-up. The presence of diagnostic imaging (92134, 3K claims, $84.9K) alongside many injection codes is consistent with management of chronic retinal diseases such as age-related macular degeneration and diabetic macular edema.

Competitive standing on specific codes is mixed: J2777 ranks #309 of 2039 providers nationally (85th percentile; typical, unremarkable volume) and J0178 ranks #969 of 3204 providers nationally (70th percentile; typical, unremarkable volume), indicating above-average but not dominant national placement for the two highest-revenue drugs. In contrast, retinal imaging via 92134 ranks #391 of 26868 providers nationally (99th percentile; extreme outlier), which implies the provider is a national outlier in OCT diagnostic imaging volume relative to peers.

Office visit E/M volumes are also above typical national levels: 99214 appears at the 95th percentile (747 claims, $64.2K) and 99213 at the 98th percentile (971 claims, $57.3K), signaling sustained ambulatory follow-up activity and high patient throughput in addition to procedure-based revenue. These elevated E/M percentiles support the view of a high-volume clinical practice managing a large panel of established patients.

Although injections and imaging dominate, surgical cataract and complex retina procedure revenue is modest: codes such as 66984 ($13.8K, 0.6%), 67108 ($16.2K, 0.7%), and 67042 ($12.1K, 0.5%) appear at relatively low shares of total Medicare revenue. This mix suggests the practice focuses more on injection-based medical retina care and diagnostics than on high volumes of cataract extraction or major vitreoretinal surgeries.

Payer concentration risk is material because Medicaid is absent: with Medicare revenue of $2.5M and no Medicaid billing on file, the provider’s publicly reported revenue base is effectively single-payer Medicare, which concentrates reimbursement exposure and strategic risk if referral patterns or payer policies change. Analysts should treat Medicaid access/growth as an unobserved or undeveloped channel in this dataset.

Several specialty-level signals point to operational scale and equipment intensity: the extreme outlier status on 92134 indicates substantial investment or throughput in retinal imaging capabilities, while meaningful billing for multiple proprietary biologic agents (J0178, J2777, J0179, J2778) suggests a practice comfortable managing a range of anti-VEGF/biologic therapies. Together these patterns are consistent with a retina-centric outpatient operation that pairs high-frequency drug administration with diagnostic imaging and frequent E/M encounters.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,320	$680	$891K
J2777	Injection, faricimab‑svoa, 0.1 mg	29,400	$30	$852.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,880	$80	$146.6K
J0179	Injection, brolucizumab-dbll, 1 mg	440	$250	$108.2K
J2778	Injection, ranibizumab, 0.1 mg	560	$180	$97.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,030	$30	$84.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	750	$90	$64.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	970	$60	$57.3K
J3490	Unclassified drugs	30	$1,720	$46.3K
J3590	Unclassified biologics	450	$70	$31.1K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Matthew Appenzeller — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	6	10	25,950	$30	$1.5M
J0178	9	20	880	$690	$722.7K
J2778	9	10	670	$180	$137.8K
J0179	1	10	440	$250	$108.3K
67028	7	20	1,070	$80	$106.4K
66984	127	200	50	$450	$75.5K
J9035	5	10	30	$50	$47.1K
J3590	7	10	430	$70	$29.7K
67042	11	10	30	$1,100	$29.6K
66821	44	80	80	$210	$23K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Matthew Appenzeller, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Physicians Clinic Inc	NE	Family Medicine Physician	$0	$20.5M
Mark Emig	NE	Ophthalmology Physician	$2.2M	$0
David Ingvoldstad	NE	Ophthalmology Physician	$1.8M	$0
Montgomery County Memorial Hospital	IA	Critical Access Hospital	$0	$1.7M
Bliss O'bryhim	MO	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Edward Taylor	NE	Internal Medicine Physician	$658.9K	$0
Michael Feilmeier	NE	Ophthalmology Physician	$617.6K	$0
Patricia Terp	NE	Ophthalmology Physician	$529.1K	$0
Thomas Franco	NE	Physical Medicine & Rehabilitation Physician	$526.6K	$0
Jesse Himebaugh	NE	Ophthalmology Physician	$412.6K	$0

Nearby Providers

Other providers in the same ZIP code as Matthew Appenzeller, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Father Flanagan's Boys' Home	NE	Pediatrics Physician	$0	$23.1M
Father Flanagan's Boys' Home	NE	Children's Hospital	$0	$16.2M
Emergency Physician Associates Of Nebraska PC	NE	Emergency Medicine Physician	$0	$4.9M
Dialysis Clinic Inc.	NE	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$3.9M
Alegent Health Bergan Mercy Health System	NE	Psychiatry Physician	$0	$3.4M
Midwest Eye Surgery Center, LLC	NE	Ambulatory Surgical Clinic/Center	$1.8M	$0
Haysam Akkad	NE	Interventional Cardiology Physician	$817.6K	$0
Pamela Helem	NE	Mental Health Counselor	$0	$680.9K
Melissa Darling	NE	Dermatology Physician	$501.5K	$0
Santa Monica	NE	Community/Behavioral Health Agency	$0	$458.5K

Matthew Appenzeller — Billing Profile & Reimbursement Data

Sign up for Matthew Appenzeller — Billing Profile & Reimbursement Data policy alerts

Matthew Appenzeller — Billing Profile & Reimbursement Data

Sign up for Matthew Appenzeller — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References